Infer Health
Infer.Health is a digital health company creating drug-device-software combination products that integrate medications with smart delivery technology and AI-powered analytics. Their flagship product, BunaTrack, secures buprenorphine-naloxone treatment for opioid use disorder using tamper-evident cartridges and a SmartKey device that authenticates patients and tracks dosing. The system pairs dose data with lab tests and symptom input to generate actionable clinical insights, achieving 97% medication compliance in patient use compared to a reference rate of 72%.
- Artificial Intelligence
- Data & Analytics
- Digital Health
- Drug Discovery & Therapeutics
- Hardware
- Healthcare Technology
- Medical Devices
- Software Only
Funding
Founders
Product
Problem
Medications that carry a high risk of misuse, diversion, or require precise adherence often lack monitoring and access controls, leaving patients and providers without objective data on treatment progress. This is especially critical for drugs like buprenorphine-naloxone for opioid use disorder, where uncontrolled use or non-compliance can lead to serious health and social consequences.
Solution
Infer.Health creates drug-device-software combination products that pair medications with smart delivery technology, dose tracking, algorithmic test regimens, and AI-powered analytics. Their flagship BunaTrack system delivers buprenorphine-naloxone in tamper-evident cartridges that can only be dispensed via a SmartKey device, which authenticates patients sprängt and controls dose access. The SmartKey logs each dose in real time and syncs with cloud servers, prompting patients for symptom input and pairing this data with lab test results. Clinicians receive detailed reports that improve Risk Evaluation and Mitigation (REMS) compliance fist and enable early detection of treatment gaps, allowing for proactive patient management.
Target Audience
The primary customers are healthcare providers and clinics that prescribe buprenorphine-naloxone for opioid use disorder treatment, as well as institutions managing high-stakes medications like oral oncolytics or drugs with narrow therapeutic indices.
Features
- Secure, tamper-evident cartridges for buprenorphine-naloxone that lock at all times and only dispense when paired with an authenticated SmartKey device
- SmartKey device that controls dose access, time-stamps each dispensation, and logs usage activity for real-time tracking
- Patient-facing app that guides and coaches users through treatment, collects symptom data, and sends reminders
- Cloud-based analytics platform that integrates dose timestamps with lab test results to generate actionable clinical insights
- Detailed clinician reports that enable early risk detection, patient portfolio review, and improved REMS compliance